BRNS Technical Analysis & Stock Price Forecast

Technical Sentiment

Overall Consensus

Sell

Buy

Technical Analysis Consensus

Sell

Buy

Moving Average Consensus

Sell

Buy

Barinthus Biotherapeutics PLC (BRNS) Moving Averages Convergence Divergence (MACD) indicator is 0.0186, suggesting BRNS is Buy.

Barinthus Biotherapeutics PLC (BRNS) 20-Day simple moving average is 0.622, while Barinthus Biotherapeutics PLC (BRNS) share price is $0.67, making it Buy.

Barinthus Biotherapeutics PLC (BRNS) 60-Day simple moving average is 0.604, while Barinthus Biotherapeutics PLC (BRNS) share price is $0.67, making it Buy.

Technical Analysis for BRNS

Technical Sentiment Analysis for Barinthus Biotherapeutics PLC (BRNS) As of 2026-05-08, Barinthus Biotherapeutics PLC (BRNS) is exhibiting a Buy technical sentiment. Our proprietary analysis, which aggregates 11 technical signals, shows that 7 indicators are flashing buy, while 4 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for BRNS stands at 61.534, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at 0.0186, providing a Buy signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 66.565 and the Commodity Channel Index (CCI) at 144.751 further confirm a 0.028 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, BRNS is trading below its 60-day moving average of $0.604 and below its 200-day long-term moving average of $0.902. Key price levels to watch include the immediate resistance at $0.707 and strong support at $0.584. A break above $0.707 could signal a bull continuation, while falling below $0.584 may test the next Fibonacci floor at $0.526.

Barinthus Biotherapeutics PLC (BRNS) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	0.461	0.526	0.584	0.649	0.707	0.772	0.83
Fibonacci	0.526	0.573	0.602	0.649	0.696	0.725	0.772

Barinthus Biotherapeutics PLC (BRNS) Technical Indicators

2026-05-08

Name	Value
RSI_14	61.534
STOCHk_14_3_3	66.565
STOCHd_14_3_3	65.636
CCI_20	144.751
AO_5_34	0.0551
MOM_10	0.028
MACD_12_26_9	0.0186

Barinthus Biotherapeutics PLC (BRNS) Relative Strength Index (RSI) is 61.534, creating a Neutral signal.

Barinthus Biotherapeutics PLC (BRNS) Stochastic Oscillator is 66.565, creating a Neutral signal.

Barinthus Biotherapeutics PLC (BRNS) Stochastic RSI is 65.636, creating a Neutral signal.

Barinthus Biotherapeutics PLC (BRNS) Commodity Channel Index (CCI) is 144.751, creating a Sell signal.

Barinthus Biotherapeutics PLC (BRNS) Awesome Oscillator is 0.0551, creating a Buy signal.

Barinthus Biotherapeutics PLC (BRNS) Momentum is 0.028, creating a Buy signal.

Barinthus Biotherapeutics PLC (BRNS) MACD is 0.0186, creating a Buy signal.

Barinthus Biotherapeutics PLC (BRNS) Moving Average

2026-05-08

Period	Simple	Signal
MA_5	0.658	Buy
MA_10	0.643	Buy
MA_20	0.622	Buy
MA_60	0.604	Buy
MA_200	0.902	Sell
MA_250	0.927	Sell

Barinthus Biotherapeutics PLC (BRNS) 5-Day simple moving average is 0.658, while Barinthus Biotherapeutics PLC (BRNS) share price is $0.67, making it a Buy.

Barinthus Biotherapeutics PLC (BRNS) 10-Day simple moving average is 0.643, while Barinthus Biotherapeutics PLC (BRNS) share price is $0.67, making it a Buy.

Barinthus Biotherapeutics PLC (BRNS) 20-Day simple moving average is 0.622, while Barinthus Biotherapeutics PLC (BRNS) share price is $0.67, making it a Buy.

Barinthus Biotherapeutics PLC (BRNS) 60-Day simple moving average is 0.604, while Barinthus Biotherapeutics PLC (BRNS) share price is $0.67, making it a Buy.

Barinthus Biotherapeutics PLC (BRNS) 200-Day simple moving average is 0.902, while Barinthus Biotherapeutics PLC (BRNS) share price is $0.67, making it a Sell.

Barinthus Biotherapeutics PLC (BRNS) 250-Day simple moving average is 0.927, while Barinthus Biotherapeutics PLC (BRNS) share price is $0.67, making it a Sell.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for BRNS?

The overall technical consensus for Barinthus Biotherapeutics PLC (BRNS) is currently Buy. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 3 buy signals and 2 sell signals.

What are the key support and resistance levels for Barinthus Biotherapeutics PLC (BRNS) today?

Based on pivot point calculations, Barinthus Biotherapeutics PLC (BRNS) has an immediate support level at 0.584 and a major resistance level at 0.707. Traders also monitor the pivot point at 0.649 to determine the intraday trend direction.

Is Barinthus Biotherapeutics PLC (BRNS) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for Barinthus Biotherapeutics PLC (BRNS) is currently 61.534. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for Barinthus Biotherapeutics PLC (BRNS)?

Barinthus Biotherapeutics PLC (BRNS) Moving Averages Convergence Divergence (MACD) indicator is 0.0186, suggesting BRNS is Buy. This indicator helps identify potential trend reversals or momentum shifts for Barinthus Biotherapeutics PLC.

How is Barinthus Biotherapeutics PLC (BRNS) performing relative to its 200-day moving average?

Barinthus Biotherapeutics PLC (BRNS) is currently trading at $0.67, which is below its 200-day simple moving average of 0.902. Trading below the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.